RNASEH2A and neoplasm: At the same time, compared with the diagnostic efficiency of simple tumor markers, HENMT1 and RNASEH2A combined with clinical markers (MKI67) have higher diagnostic efficiency and reduce the misdiagnosis and missed diagnosis rate of patients to a certain extent.